Publications by authors named "Karl Smith Byrne"

Uncertainty remains regarding the role of diet in colorectal cancer development. We examined associations of 97 dietary factors with colorectal cancer risk in 542,778 Million Women Study participants (12,251 incident cases over 16.6 years), and conducted a targeted genetic analysis in the ColoRectal Transdisciplinary Study, Colon Cancer Family Registry, and Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO).

View Article and Find Full Text PDF
Article Synopsis
  • Previous models for predicting weight gain haven't been very effective, leading researchers to explore both traditional environmental factors and genetic markers to enhance accuracy.* -
  • A study involving nearly 246,000 participants found that environmental factors provided good predictive ability for weight gain, while genetic models performed poorly, especially at mid-late adulthood.* -
  • The research suggests that environmental factors should be incorporated into prevention strategies, and that genetic factors may be more relevant in predicting weight gain earlier in life.*
View Article and Find Full Text PDF

Biological mechanisms related to cancer development can leave distinct molecular fingerprints in tumours. By leveraging multi-omics and epidemiological information, we can unveil relationships between carcinogenesis processes that would otherwise remain hidden. Our integrative analysis of DNA methylome, transcriptome, and somatic mutation profiles of kidney tumours linked ageing, epithelial-mesenchymal transition (EMT), and xenobiotic metabolism to kidney carcinogenesis.

View Article and Find Full Text PDF

Experimental research has uncovered lipocalin 2 (LCN2) as a novel biomarker implicated in the modulation of intestinal inflammation, metabolic homeostasis, and colon carcinogenesis. However, evidence from human research has been scant. We, therefore, explored the association of pre-diagnostic circulating LCN2 concentrations with incident colorectal cancer (CRC) in a nested case-control study within the in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

View Article and Find Full Text PDF
Article Synopsis
  • * No significant associations were found between individual metabolites or patterns and overall prostate cancer risk after adjusting for multiple tests, except for six specific phosphatidylcholines linked to advanced cases diagnosed within 10 years.
  • * Two metabolite patterns (1 and 2) showed inverse associations with advanced prostate cancer, while pattern 3 was related to prostate cancer death, indicating that metabolite profiles may change several years before advanced disease is detected.
View Article and Find Full Text PDF
Article Synopsis
  • Inflammation plays a significant role in breast cancer progression and prognosis, particularly through pre-diagnostic plasma biomarkers in women.
  • A study involving 1,538 women showed that elevated levels of the inflammatory marker IL-6 were linked to increased risks of all-cause and breast cancer-specific mortality, especially in postmenopausal women.
  • Higher levels of IL-10 and TNFα were also associated with all-cause mortality, and an inflammatory score could indicate poorer long-term survival, particularly in postmenopausal breast cancer survivors.
View Article and Find Full Text PDF

HPV-positive and HPV-negative head and neck squamous cell carcinoma (HNSCC) are recognized as distinct entities. There remains uncertainty surrounding the causal effects of smoking and alcohol on the development of these two cancer types. Here we perform multivariable Mendelian randomization (MR) to evaluate the causal effects of smoking and alcohol on the risk of HPV-positive and HPV-negative HNSCC in 3431 cases and 3469 controls.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied proteins in the blood to understand how they relate to prostate cancer risk.
  • They found 20 proteins connected to different types of prostate cancer, including aggressive and early onset forms.
  • One protein, MSMB, was especially important because it helped tell the difference between normal tissue and cancerous tissue.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how genetic variants affect the relationship between heavy alcohol consumption and the risk of pancreatic cancer, utilizing data from a sizable European ancestry population.
  • - Researchers identified a new relevant genomic region (10p11.22) linked to pancreatic cancer risk and a specific SNP (rs7898449) that suggests this association is influenced by heavy alcohol consumption.
  • - The findings highlight the potential role of the neuropilin 1 gene in pancreatic cancer development, offering new insights into cancer risk factors, especially among heavy drinkers.
View Article and Find Full Text PDF
Article Synopsis
  • Circulating free insulin-like growth factor-I (IGF-I) was studied to determine its relationship with prostate cancer risk by analyzing data from 767 cases and 767 matched controls in a long-term cohort.
  • The study found that levels of circulating free IGF-I were not significantly associated with overall prostate cancer risk, tumor stage, or histological grade.
  • Researchers suggest further investigation into different methods of assessing bioavailable IGF-I to better understand its connection to prostate cancer, given the known link between total IGF-I levels and cancer risk.
View Article and Find Full Text PDF

Background: The mechanisms underlying alcohol-induced breast carcinogenesis are not fully understood but may involve hormonal changes.

Methods: Cross-sectional associations were investigated between self-reported alcohol intake and serum or plasma concentrations of estradiol, estrone, progesterone (in premenopausal women only), testosterone, androstenedione, dehydroepiandrosterone sulfate, and sex hormone binding globulin (SHBG) in 45 431 premenopausal and 173 476 postmenopausal women. Multivariable linear regression was performed separately for UK Biobank, European Prospective Investigation into Cancer and Nutrition, and Endogenous Hormones and Breast Cancer Collaborative Group, and meta-analyzed the results.

View Article and Find Full Text PDF
Article Synopsis
  • The UK Biobank data allows researchers to study links between plasma proteins and cancer risks, analyzing 1463 proteins across 19 cancers over an average follow-up of 12 years.
  • Out of 618 identified protein-cancer associations, 107 were persistent for diagnoses occurring more than seven years after initial blood draw, indicating potential early indicators of cancer risk.
  • Four specific proteins (CD74, TNFRSF1B, ADAM8, SFTPA2) showed strong connections to different cancers, suggesting they could play a role in cancer development and risk prediction.
View Article and Find Full Text PDF

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden. In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence. Underlying causes can be inferred by sequencing the genomes of cancers from populations with different incidence rates and detecting differences in patterns of somatic mutations.

View Article and Find Full Text PDF
Article Synopsis
  • * Our research uncovered 40 proteins linked to cancer risks, including PLAUR for breast cancer and CTRB1 for pancreatic cancer, while also noting possible negative side effects like hypertension from altering these proteins.
  • * We found 18 proteins that are associated with cancer risk and linked to existing drugs, plus 15 proteins not yet being studied for clinical use, enhancing our understanding of cancer causes and the implications of targeting these proteins for prevention.
View Article and Find Full Text PDF

Background: Tumour-promoting inflammation is a "hallmark" of cancer and conventional epidemiological studies have reported links between various inflammatory markers and cancer risk. The causal nature of these relationships and, thus, the suitability of these markers as intervention targets for cancer prevention is unclear.

Methods: We meta-analysed 6 genome-wide association studies of circulating inflammatory markers comprising 59,969 participants of European ancestry.

View Article and Find Full Text PDF

Background: Type 2 diabetes is associated with higher risk of several cancer types. However, the biological intermediates driving this relationship are not fully understood. As novel interventions for treating and managing type 2 diabetes become increasingly available, whether they also disrupt the pathways leading to increased cancer risk is currently unknown.

View Article and Find Full Text PDF

Purpose: There is strong evidence that leisure-time physical activity is protective against postmenopausal breast cancer risk but the association with premenopausal breast cancer is less clear. The purpose of this study was to examine the association of physical activity with the risk of developing premenopausal breast cancer.

Methods: We pooled individual-level data on self-reported leisure-time physical activity across 19 cohort studies comprising 547,601 premenopausal women, with 10,231 incident cases of breast cancer.

View Article and Find Full Text PDF

Background: The association of fitness with cancer risk is not clear.

Methods: We used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of lung, colorectal, endometrial, breast, and prostate cancer in a subset of UK Biobank participants who completed a submaximal fitness test in 2009-12 (N = 72,572). We also investigated relationships using two-sample Mendelian randomisation (MR), odds ratios (ORs) were estimated using the inverse-variance weighted method.

View Article and Find Full Text PDF

Biomarkers for early detection of breast cancer may complement population screening approaches to enable earlier and more precise treatment. The blood proteome is an important source for biomarker discovery but so far, few proteins have been identified with breast cancer risk. Here, we measure 2929 unique proteins in plasma from 598 women selected from the Karolinska Mammography Project to explore the association between protein levels, clinical characteristics, and gene variants, and to identify proteins with a causal role in breast cancer.

View Article and Find Full Text PDF

Background: Understanding the role of circulating proteins in prostate cancer risk can reveal key biological pathways and identify novel targets for cancer prevention.

Methods: We investigated the association of 2,002 genetically predicted circulating protein levels with risk of prostate cancer overall, and of aggressive and early onset disease, using -pQTL Mendelian randomization (MR) and colocalization. Findings for proteins with support from both MR, after correction for multiple-testing, and colocalization were replicated using two independent cancer GWAS, one of European and one of African ancestry.

View Article and Find Full Text PDF

Background: We evaluated the temporal association between kidney function, assessed by estimated glomerular filtration rate (eGFR), and the risk of incident renal cell carcinoma (RCC). We also evaluated whether eGFR could improve RCC risk discrimination beyond established risk factors.

Methods: We analyzed the UK Biobank cohort, including 463,178 participants of whom 1,447 were diagnosed with RCC during 5,696,963 person-years of follow-up.

View Article and Find Full Text PDF

Background: The mechanisms underlying alcohol-induced breast carcinogenesis are not fully understood but may involve hormonal changes.

Methods: We investigated cross-sectional associations between self-reported alcohol intake and serum or plasma concentrations of oestradiol, oestrone, progesterone (in pre-menopausal women only), testosterone, androstenedione, DHEAS (dehydroepiandrosterone sulphate) and SHBG (sex hormone binding globulin) in 45 431 pre-menopausal and 173 476 post-menopausal women. We performed multivariable linear regression separately for UK Biobank, EPIC (European Prospective Investigation into Cancer and Nutrition) and EHBCCG (Endogenous Hormones and Breast Cancer Collaborative Group), and meta-analysed the results.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to understand the link between different types of adiposity (metabolically unfavorable and favorable) and the risk of aggressive prostate cancer using Mendelian randomization.
  • Researchers analyzed data from the PRACTICAL consortium, including over 15,000 aggressive prostate cancer cases, to evaluate the genetic influence of various adiposity traits on cancer risk.
  • The findings indicated no strong associations between either type of adiposity or body mass index (BMI) and aggressive prostate cancer, suggesting metabolic factors aren't the primary influencers of prostate cancer risk, but further research is needed to investigate other potential links.
View Article and Find Full Text PDF

Background: Renal cell carcinoma (RCC) is twice as common among men compared with women, and hormonal factors have been suggested to partially explain this difference. There is currently little evidence on the roles of reproductive and hormonal risk factors in RCC aetiology.

Materials & Methods: We investigated associations of age at menarche and age at menopause, pregnancy-related factors, hysterectomy and ovariectomy and exogenous hormone use with RCC risk among 298,042 women in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

View Article and Find Full Text PDF